Expression of Interest (EOI): FIND is seeking an in-vitro diagnostic (IVD) partner to apply to a Horizon Europe call for the translation of a host-response mRNA signature to a portable point-of-care molecular diagnostic platform and advancing the assay to market in LMICs

Last update: Nov 2, 2026

Details

Location: Afghanistan, Algeria, Angola, Bangladesh, Belize, Benin, Bhutan, Bolivia, Burkina Faso, Burundi, Cambodia, Cameroon, Cape Verde, Central African Republic, Chad, Comoros, Congo, Cote d'Ivoire, Dem. Rep. Congo, Djibouti, Egypt, El Salvador, Eritrea, Eswatini (Swaziland), Ethiopia, Gambia, Ghana, Guinea, Guinea-Bissau, Haiti, Honduras, India, Indonesia, Iran, Kenya, Kiribati, Kyrgyzstan, Laos, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Micronesia, Mongolia, Morocco, Mozambique, Myanmar, Nepal, Nicaragua, Niger, Nigeria, North Korea, Pakistan, Palestine / West Bank & Gaza, Papua New Guinea, Philippines, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Solomon Islands, Somalia, South Sudan, Sri Lanka, Sudan, Syria, Tajikistan, Tanzania, Timor-Leste, Togo, Tunisia, Uganda, Ukraine, Uzbekistan, Vanuatu, Vietnam, Yemen, Zambia, Zimbabwe

Funding Agency: Horizon Europe (2021 - 2027)

Contracting Authority: FIND - Foundation for Innovative New Diagnostics

Status: Open

Budget: N/A

Award ceiling: N/A

Award floor: N/A

Sector: Health, Laboratory & Measurement, Research & Innovation

Eligible applicants: Academic Institutions, Private Sector

Eligible nationalities: Worldwide

Date posted: Oct 14, 2026

Quick Summary

Objectives:

Objectives

Purpose: Identify an in-vitro diagnostic partner to join a Horizon Europe consortium for translating a host-response mRNA signature onto a portable point-of-care or ne...

Eligibility criteria:

Eligible applicants: Companies that are the original developer/manufacturer of a molecular POC or near-patient diagnostic platform. Academic teams may be considered case by case only if they can demonstrate a clear path to market, including design controls, manufacturing and distribution capacity, and an industry partnership.
Commercial and technical eligibility: The applicant must be a mature company with at least one IVD product already commercially available with active sales, and the proposed...